MDT
86.53
+0.49%↑
A
114.87
+1.31%↑
VEEV
173.27
-1.41%↓
HQY
81.97
+0.15%↑
CSBR
5.55
-0.72%↓
MDT
86.53
+0.49%↑
A
114.87
+1.31%↑
VEEV
173.27
-1.41%↓
HQY
81.97
+0.15%↑
CSBR
5.55
-0.72%↓
MDT
86.53
+0.49%↑
A
114.87
+1.31%↑
VEEV
173.27
-1.41%↓
HQY
81.97
+0.15%↑
CSBR
5.55
-0.72%↓
MDT
86.53
+0.49%↑
A
114.87
+1.31%↑
VEEV
173.27
-1.41%↓
HQY
81.97
+0.15%↑
CSBR
5.55
-0.72%↓
MDT
86.53
+0.49%↑
A
114.87
+1.31%↑
VEEV
173.27
-1.41%↓
HQY
81.97
+0.15%↑
CSBR
5.55
-0.72%↓
24 ч
Текуща
Минимум
1.74
Максимум
1.8
Миналото представяне не гарантира бъдещи резултати.
31.03.2026 г., 23:31 ч. UTC
Stocks to Watch: Nike, RH, NCino
DJ
Прочетени
31.03.2026 г., 22:35 ч. UTC
Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update
DJ
Прочетени
1.04.2026 г., 00:00 ч. UTC
The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ
DJ
Прочетени
31.03.2026 г., 23:50 ч. UTC
Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO
DJ
Прочетени
31.03.2026 г., 23:43 ч. UTC
Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk
DJ
Прочетени
31.03.2026 г., 23:33 ч. UTC
Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk
DJ
Прочетени
31.03.2026 г., 23:21 ч. UTC
Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com
DJ
Прочетени
31.03.2026 г., 23:14 ч. UTC
Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk
DJ
Прочетени
31.03.2026 г., 23:12 ч. UTC
Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk
DJ
Прочетени
31.03.2026 г., 22:36 ч. UTC
China Vanke 2025 Loss Widens >000002.SZ
DJ
Прочетени
31.03.2026 г., 22:36 ч. UTC
China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ
DJ
Прочетени
31.03.2026 г., 22:36 ч. UTC
China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ
DJ
Прочетени
31.03.2026 г., 22:36 ч. UTC
China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ
DJ
Прочетени
31.03.2026 г., 22:36 ч. UTC
China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ
DJ
Прочетени
31.03.2026 г., 21:46 ч. UTC
Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ
DJ
Прочетени
31.03.2026 г., 21:36 ч. UTC
West African Resources's Costs Higher Than Bull Expected -- Market Talk
DJ
Прочетени
31.03.2026 г., 21:35 ч. UTC
Nike Expects China Sales Down 20% in 4Q, CFO Says
DJ
Прочетени
31.03.2026 г., 21:35 ч. UTC
Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says
DJ
Прочетени
31.03.2026 г., 21:35 ч. UTC
Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says
DJ
Прочетени
31.03.2026 г., 21:33 ч. UTC
Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com
DJ
Прочетени
31.03.2026 г., 21:33 ч. UTC
Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says
DJ
Прочетени
31.03.2026 г., 21:32 ч. UTC
Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says
DJ
Прочетени
31.03.2026 г., 21:28 ч. UTC
Nike Expects to End 4Q With Elevated Inventory, CFO Says
DJ
Прочетени
31.03.2026 г., 21:26 ч. UTC
Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says
DJ
Прочетени
31.03.2026 г., 21:25 ч. UTC
Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says
DJ
Прочетени
31.03.2026 г., 21:24 ч. UTC
Nike: Turnaround Plan Progressing at Different Rates -- Market Talk
DJ
Прочетени
31.03.2026 г., 21:22 ч. UTC
Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters
DJ
Прочетени
31.03.2026 г., 21:22 ч. UTC
Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says
DJ
Прочетени
31.03.2026 г., 21:21 ч. UTC
Nike's Digital Channel Still Too Promotional, CFO Says
DJ
Прочетени
31.03.2026 г., 21:20 ч. UTC
Nike CEO: Converse Remains Important to Portfolio
DJ
Прочетени
Ценова промяна
By TipRanks
0 ratings
0
Купи
0
Задържане
0
Продай
Според 0 анализатори, дали борсови рейтинги на Dare Bioscience Inc през последните 3 месеца.
$